Sections
| Title | Starting Page | Number of Pages |
|---|
| Table of Contents | 4 | 5 |
| List of Tables | 7 | 1 |
| List of Figures | 7 | 2 |
| Pharmaceutical Packaging Industry - Introduction | 9 | 1 |
| GBI Research Report Guidance | 9 | 1 |
| Pharmaceutical Packaging Industry - Overview | 10 | 7 |
| Introduction | 10 | 1 |
| Key Aspects of Packaging | 11 | 1 |
| Industry Segments in Pharmaceutical Packaging | 12 | 1 |
| Blister Packaging | 13 | 1 |
| Plastic Bottles | 13 | 1 |
| Labels and Accessories | 13 | 1 |
| Drug Delivery Devices | 13 | 1 |
| Pouches and Strip Packs | 13 | 1 |
| Caps and Closures | 13 | 1 |
| Secondary Containers | 14 | 1 |
| Others | 14 | 1 |
| Market Size in 2010 | 14 | 3 |
| Pharmaceutical Packaging Industry - Market Drivers, Barriers and Key Trends | 17 | 13 |
| Drivers | 18 | 1 |
| Packaging Market Will Capitalize on the Growing Counterfeit Market | 18 | 1 |
| Growing Pharmaceutical Market Will Lead to Growth in the Pharmaceutical Packaging Market | 19 | 1 |
| Innovation in Packaging Industry is Required to Improve the Compliance Rate | 20 | 1 |
| Aging Population Will Lead to Growth in the Pharmaceutical Market | 21 | 1 |
| Patent Cliff Will Strengthen the Generic Market | 22 | 1 |
| Barriers | 23 | 1 |
| Complex Pharmaceutical Industry Regulations Influence Packaging Industry Revenues | 23 | 1 |
| Changes in Health Regulations Adversely Affect the Pharmaceutical Packaging Industry | 24 | 1 |
| Global Operations for Pharmaceutical Packaging are Subject to Political, Regulatory and Economic Risks | 25 | 1 |
| Consistent Quality is a Challenge for the Packaging Industry | 26 | 1 |
| The Availability and Price Volatility of Raw Materials is a Problem for Pharmaceutical Packaging Companies | 27 | 1 |
| Key Trends | 28 | 1 |
| Greater Proportion of Resources Spent on Anti-Counterfeiting Measures | 28 | 1 |
| Innovative Packaging Requirements for Specific Disorders | 28 | 1 |
| The Right Package for Baby Boomers | 29 | 1 |
| Compliance is a Key Factor | 29 | 1 |
| The Rise of Unit Dosing | 29 | 1 |
| Pharmaceutical Packaging Industry - Regulatory Framework | 30 | 5 |
| International Standards for Pharmaceutical Packaging | 30 | 1 |
| PS 9000:2001 - Pharmaceutical Packaging Materials | 30 | 1 |
| ISO 15378: 2006 | 31 | 1 |
| National Guidelines for Pharmaceutical Packaging | 32 | 1 |
| Regulatory Framework in the US | 32 | 1 |
| Regulatory Framework in Europe | 33 | 1 |
| Regulatory Framework in Asia Pacific | 34 | 1 |
| Overview | 34 | 1 |
| Pharmaceutical Packaging Industry - Geographical Landscape | 35 | 10 |
| Geographical Split | 35 | 1 |
| Geographical Trends | 36 | 1 |
| Pharmaceutical Packaging in the APAC Region will Grow Faster than the US and Europe | 36 | 1 |
| Packaging Industry Growth in Emerging Nations Will be Faster than in Developed Nations | 36 | 1 |
| Emerging Markets | 37 | 1 |
| China | 37 | 1 |
| Overview | 37 | 1 |
| Porter s Diamond | 37 | 1 |
| Trends | 38 | 1 |
| India | 39 | 1 |
| Overview | 39 | 1 |
| Porter s Diamond | 39 | 1 |
| Trends | 40 | 1 |
| Brazil | 41 | 1 |
| Overview | 41 | 1 |
| Porter s Diamond | 41 | 1 |
| Trends | 42 | 1 |
| Russia | 43 | 1 |
| Overview | 43 | 1 |
| Porter s Diamond | 43 | 1 |
| Trends | 44 | 1 |
| Pharmaceutical Packaging Industry - Competitive Landscape | 45 | 26 |
| Rexam | 45 | 1 |
| Business Description | 46 | 1 |
| Financial Performance | 46 | 1 |
| Recent Development | 47 | 1 |
| Schott | 47 | 1 |
| Business Description | 48 | 1 |
| Financial Performance | 48 | 1 |
| Recent Development | 49 | 1 |
| Nypro | 49 | 1 |
| Business Description | 50 | 1 |
| Financial Performance | 50 | 1 |
| Recent Development | 51 | 1 |
| Consort Medical | 51 | 1 |
| Business Description | 52 | 1 |
| Financial Performance | 52 | 1 |
| Recent Developments | 53 | 1 |
| Becton Dickinson (BD) | 53 | 1 |
| Business Description | 54 | 1 |
| Financial Performance | 54 | 1 |
| Recent Developments | 55 | 1 |
| Gerresheimer | 55 | 1 |
| Business Description | 56 | 1 |
| Financial Performance | 56 | 1 |
| Recent Developments | 57 | 1 |
| West Pharmaceutical Services | 57 | 1 |
| Business Description | 58 | 1 |
| Recent Developments | 58 | 1 |
| Amcor | 59 | 1 |
| Business Description | 60 | 1 |
| Financial Performance | 60 | 1 |
| Recent Developments | 60 | 1 |
| Ypsomed | 61 | 1 |
| Business Description | 62 | 1 |
| Financial Performance | 62 | 1 |
| Recent Development | 62 | 1 |
| Bormiolli Rocco | 63 | 1 |
| Business Description | 64 | 1 |
| Recent Development | 64 | 1 |
| Duran | 65 | 1 |
| Business Description | 66 | 1 |
| Recent Developments | 66 | 1 |
| Catalent | 67 | 1 |
| Business Description | 68 | 1 |
| Financial Performance | 68 | 1 |
| Recent Developments | 68 | 1 |
| MeadWestvaco | 69 | 1 |
| Business Description | 70 | 1 |
| Financial performance | 70 | 1 |
| Recent Developments | 70 | 1 |
| Pharmaceutical Packaging Industry - Strategic Consolidations | 71 | 2 |
| Overview | 71 | 1 |
| Consort Medical Acquires The Medical House (TMH) | 71 | 1 |
| BD Acquires Handylab and Accuri Cytometers | 71 | 1 |
| Gerresheimer Acquires Vedat | 71 | 1 |
| Amcor Acquires Alcan Pharma Plastics Packaging and Ball Plastics Packaging Americas | 72 | 1 |
| Pharmaceutical Packaging Industry - Appendix | 73 | 4 |
| Market Definitions | 73 | 1 |
| Abbreviations | 73 | 1 |
| Research Methodology | 73 | 2 |
| Coverage | 73 | 1 |
| Secondary Research | 74 | 1 |
| Primary Research | 74 | 1 |
| Expert Panel Validation | 74 | 1 |
| Section-wise Methodology | 75 | 2 |
| Trends, Market Barriers and Drivers in the Pharmaceutical Packaging Industry | 75 | 1 |
| The Regulatory Framework of Pharmaceutical Packaging Industry | 75 | 1 |
| Geographical Landscape | 75 | 1 |
| Company Profiling | 75 | 1 |
| Strategic Consolidations | 76 | 1 |
| Contact Us | 76 | 1 |
| Disclaimer | 76 | 1 |
| Sources | 76 | 1 |